We aimed to determine the growth and safety parameters in newborns fed a goat milk based infant formula (Kabrita) using a randomized double-blind trial, in which a cow milk formula served as a control and a breast fed group as a reference. Healthy term infants (n=304) aged up to 14 days old were recruited from 25 European study centers. Our data demonstrate that Kabrita provides adequate growth, has a good tolerability, and is safe to use in infants.
Want to know more? Click here for more information about this clinical trial
Interested to learn more about our brands and our company? Check out our other news posts!
Kabrita, goat milk infant formula, has won the Product of the Year award in the Gulf Region this year. A great achievement, because products from over 45 countries worldwide compete for this award. The Product of the Year election has been held for more than 30 years to help guide consumers to the best products …
Cooperation RUG, UMCG & Ausnutria on new publication: The effect of calcium palmitate on bacteria associated with infant gut microbiota Randolph Happe, Head of Research & Development “As a company and as an R&D department, we really want to be involved in the progress of the research.” Proper nutrition supports the development of healthy bacteria …
In collaboration with dr. A. López Escobar (HM Hospitales, Madrid, Spain), Ausnutria’s research team performed a study in infants with mild gastro-intestinal discomfort. The study showed that Kabrita significantly reduced the discomfort in these infants after two weeks. Infants using Kabrita showed a faster reduction of discomfort than infants using a cow’s milk formula. Moreover, the study …